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Abstract
Background: Primary intramedullary neurocytoma is extremely rare. Due to its 
rarity, it is difficult to collect a wide series in a single institution to perform a survival 
analysis and give indications about prognosis and treatment.
Case Description: Here, we report on a case of a 37‑year‑old woman with primary 
intramedullary neurocytoma and perform a systematic statistical analysis of cases 
reported in the literature. Of 21 articles found, 15 studies and the present case 
(22 patients) were eligible for the analysis. We studied the impact of age, sex, 
number of involved levels (≤2 vs. >2), entity of resection, postoperative radiotherapy 
(RT), proliferation index (Ki67) on the neurological outcome of patients, and on the 
recurrence of the tumor. Comparison of categorical variables was performed by the 
χ2 statistic. The Kaplan–Meier curves were plotted to calculate the progression‑free 
survival (PFS) of these patients. P < 0.05 was considered as statistically significant. 
The 1‑year PFS was 95.45% and the 2‑year PFS was 86.36%. A gross total resection 
was associated to a worsening of the neurological function with no impact on the 
tumor recurrence. Adjuvant RT significantly improved the neurological function. 
A lower Ki67 was strongly associated with a lower tumor recurrence.
Conclusions: We think that the goal of the surgery should be to preserve a good 
neurological function even if a residual tumor has to be left. Ki67 should be always 
evaluated due to its impact on the prognosis. Although adjuvant RT significantly 
improved the neurological function, its role in preventing the tumor recurrence is 
not clearly defined.
Key Words: Adjuvant radiotherapy, intramedullary neurocytoma, Ki67, 
progression‑free survival, surgery
INTRODUCTION
Primary intramedullary neurocytoma, first described by 
Coca et al.,[3] is extremely rare. It has been hypothesized 
that intramedullary neurocytoma can originate from 
the primitive neuroectodermal cells surrounding the 
central canal region in fetal life. Due to the rarity of 
this pathology, only a few cases have been reported in 
the literature.[1‑3,5,9‑19] Moreover, it is difficult to collect 
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a wide series in a single institution in order to perform 
a survival analysis and give indications about prognosis 
and treatment. Thus, the aim of this study was to report 
a case of primary intramedullary neurocytoma and to 
perform a systematic statistical analysis of cases reported 
in the literature in order to identify potentially prognostic 
factors on neurological outcome and recurrence risk.
CASE REPORT
A 37‑year‑old woman was admitted because of a 
9 months history of diffuse axial and low back pain. 
The neurological examination showed a hypesthesia 
in the left lower limb and bilateral hyperactive deep 
tendon reflexes. Spinal magnetic resonance imaging 
(MRI) with gadolinium showed an intramedullary 
lesion at T8–T9 level, with solid and cystic components, 
hypo‑ and hyper‑intense on T2‑weighted images and with 
dishomogeneous contrast enhancement after gadolinium 
administration associated to the cranial syrinx [Figure 1]. 
Under neurophysiological intraoperative monitoring, the 
patient was submitted to T8–T9 laminotomy and total 
lesion removal. On histology, the lesion was composed of 
round to the oval cells with finely dispersed chromatin 
and small nucleoli; ganglion cell differentiation was 
commonly present among the neurocytic cells. Hyalinized 
vessels were also observed [Figure 2a]. “Atypical” 
histological features (mitotic activity, microvascular 
proliferation, and necrosis) were not present. 
Immunohistochemically, the neoplastic cells were positive 
for synaptophysin [Figure 2b]. The MIB‑1 labeling index 
was 1%. The histological diagnosis of extraventricular 
neurocytoma with ganglion cell differentiation was made. 
Postoperative course was uneventful. The patient is in 
good neurological conditions after 1‑year follow‑up.
DISCUSSION
A literature search was made in the PubMed database 
including the following terms: Neurocytoma, spinal 
neurocytoma, neurocytoma of the spinal cord, 
intramedullary neurocytoma, and extraventricular 
neurocytoma. Twenty‑one articles were found. We 
excluded from the analysis articles with a follow‑up fewer 
than 6 months or with no information about the follow‑up. 
Fifteen articles[1‑3,5,9‑19] and the present case (22 patients, 
15/male, 7/female) were eligible for the analysis. The 
clinical and outcome data are reported in Table 1. We 
studied the impact of age, sex, number of involved 
levels (≤2 vs. >2), entity of resection (subtotal vs. gross 
total), postoperative radiotherapy (RT), and proliferation 
index (Ki67) on the neurological outcome of the patients 
and on the recurrence of the tumor. Comparison of 
categorical variables was performed by the χ2 statistic. 
The Kaplan–Meier curves were plotted to calculate the 
progression‑free survival (PFS) of these patients. P < 0.05 
was considered as statistically significant. The mean age 
of the selected patients was 36.45 ± 17.77 years with 
a mean follow‑up of 38.18 ± 58.46 months. A subtotal 
resection (STR) was achieved in 14 (64%)[1,2,5,11,12,16,17,19] 
while a gross total resection (GTR) was feasible only in 7 
cases [3,9,10,13‑15,18] and in the present case (36%). Adjuvant 
RT was performed only in 7 patients (31.81%).[1,12,16,17] 
The clinical outcome at follow‑up was reported stable 
in 4 cases[1,11,12] and improved in the present case and in 
11 [2,3,5,10,11,14‑17] from the literature, with an overall good 
functional outcome in 72.72% of patients. The mean PFS 
was 22.65 ± 1.11 months [Figure 3] with a 1‑year PFS of 
95.45% and a 2‑year PFS of 86.36%.
Among the considered potentially prognostic factors, 
we found a statistically significant better neurological 
outcome in the patients who underwent adjuvant RT 
(P = 0.04). All the patients with a number of involved 
levels ≤2 [Table 1] reported a stable or improved 
Figure 1: Spinal magnetic resonance imaging. (a) T2-weighted 
sagittal sequences showing the intramedullary lesion at T8–T9 level 
(yellow arrow), with solid (hypointense) and cystic (hyperintense) 
components. The cranial syringomyelia is evident (red arrow). 
(b) T2-weighted axial sequences demonstrating that the tumor is 
mainly located on the left spinal cord. T1-weighted sagittal (c) and 
axial (d) after gadolinium administration sequences showing the 
dishomogeneous contrast enhancement of the lesion
b
a
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Figure 2: (a, ×400) H and E stain of the lesion showing a 
neoplasm composed of round to oval cells with finely speckled 
chromatin pattern and small nucleoli. Ganglion cell differentiation 
was commonly present among neurocytic cells. (b, ×400) 
Immunohistochemically, the neoplastic cells were positive for 
synaptophysin. The MIB-1 labeling index was 1% (not showed)
ba
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clinical outcome at follow‑up but this data did not 
reach statistical significance on the analysis (P = 0.05). 
Considering the recurrence risk, a Ki67 (MIB‑1) lower 
than 2% was associated with a statistically significant 
lower risk of recurrence (P = 0.0157).
The primary intramedullary neurocytoma represents a 
challenge for a neurosurgeon. Preoperative radiological 
diagnosis can be difficult due to the rarity of this pathology. 
Moreover, the extremely variable features on MRI make 
the differential diagnosis very hard. Likewise astrocytoma, 
its signal can range from iso‑ to hypo‑intensity on 
T1‑weighted images and iso‑ to hyper‑intensity on 
T2‑weighted images, with homo‑ or hetero‑geneous 
contrast enhancement.[4] Moreover, it can show cystic 
components or intratumoral hemorrhage similarly to 
ependymomas and hemangioblastomas and can display 
the exophytic growth mimicking a meningioma.[17,18] 
From a surgical point of view, from our literature analysis, 
it appears evident how it usually involves more spinal 
segment (70% of reported cases, Table 1) and that a GTR 
is very difficult to achieve (only 36% of cases). Thus, the 
preservation of a good functional outcome with a STR 
instead of a GTR should be kept in mind approaching an 
intramedullary neurocytoma. In fact, from our analysis, 
we found a worsening of the neurological function in 
3 out of 5 patients (60%) submitted to GTR and only 
in 3 out of 14 cases (21.42%) who underwent a STR. 
Moreover, a GTR did not significantly decrease the risk 
of the recurrence being a lower Ki67 (MIB‑1) the factor 
more strongly related to a lower tumor recurrence. Thus, 
the histopathological examination is crucial both to 
make the diagnosis (based on some peculiarities, such as 
the presence of ganglion cell differentiation, lower cell 
density and immunoreactivity for glial fibrillary acidic 
Table 1: Clinical and outcome findings of primary intramedullary neurocytoma studies included in the analysis
Author, year Age Sex Location Resection RT Ki-67 (%) PFS 
(months)
Follow-up 
(months)
Recurrence Neurological 
function at follow-up
Tatter et al., 1994[17] 65 Male C2-C6 STR Yes NA 120 120 Not Improved
49 Male C3-C4 STR Yes NA 24 60 Yes Improved
Coca et al., 1994[3] 67 Male T11-T12 GTR Not NA 30 30 Not Improved
Stapleton et al., 1997[14] 12 Male C4-T1 GTR Not NA 24 24 Not Improved
Stephan et al., 1999[15] 46 Female T12-L1 GTR Not 1 12 12 Not Improved
Ashkan et al., 2000[2] 12 Male C6-T1 STR Not NA 33 33 Not Improved
Martin et al., 2002[9] 50 Male T2-T5 GTR Not 2 24 24 Not Worsened
Sharma et al., 2005[13] 24 Male C5-T1 GTR Not 9 10 24 Yes Worsened; dead for 
intracranial metastasis
Gokhan et al., 2008[5] 49 Female C3-C6 STR Not 1 7 7 Not Improved
Marucci et al., 2009[10] 51 Male T10-T11 GTR Not 1 12 12 Not Improved
Polli et al., 2009[12] 6 Male C1-C7 STR Not 1 276 276 Not Worsened
15 Male C1-T11 STR Not 1 24 24 Not Worsened
37 Female T12-L1 STR Yes 5 15 27 Yes Stable
Tsai et al., 2011[18] 54 Female T3-T5 GTR Not 1 6 6 Not Worsened
Agarwal et al., 2011[1] 16 Male NA STR Yes NA 6 6 Not Stable
25 Male NA STR Yes NA 6 6 Not Stable
Wu et al., 2014[19] 48 Female Medulla-T1 STR Not NA 18 18 Not Worsened
Patil et al., 2014[11] 26 Male Medulla-T4 STR Not NA 24 24 Not Improved
39 Male T9-L1 STR Not NA 44 44 Not Stable
Sun et al., 2015[16] 26 Male Medulla-T4 STR Yes NA 24 24 Not Improved
48 Female Medulla-T2 STR Yes NA 24 24 Not Improved
Present case 37 Female T8-T10 GTR Not 1 15 15 Not Improved
RT: Radiotherapy, PFS: Progression free survival, STR: Subtotal resection, GTR: Gross total resection, NA: Not available
Figure 3: The Kaplan–Meier analysis of progression-free survival of 
cases included in this review
Surgical Neurology International 2015, 6:178 http://www.surgicalneurologyint.com/content/6/1/178
protein, synaptophysin, and NeuN, markers for glial and 
neuronal differentiation[6‑8]) and to get the proliferative 
index (MIB‑1). Due to its importance for the prognosis, 
this data should be routinely investigated (in our analysis 
it was available only in 10 out of 22 cases [45.45%]). 
However, the future research should clarify if a higher 
proliferative index should be considered as an indication 
for RT. In our analysis, RT seems to play a role in 
improving the neurological outcome at follow‑up but not 
in preventing the tumor recurrence.
We tried to obtain some indications about the 
management of the primary intramedullary neurocytoma 
making an analysis of available cases in the literature. 
Although our study has some limitations, due to the 
heterogeneous nature of data, we think that the goal of 
the surgery should be to preserve a good neurological 
function even if a residual tumor has to be left. In fact, 
a GTR did not seem affect the tumor recurrence but is 
associated to a worsening of the neurological function in 
most of the cases. Moreover, the Ki67 (MIB‑1) should 
be always evaluated because it seems strongly associated 
with the tumor recurrence. Further studies should clarify 
the role of adjuvant RT.
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